PRIME MEDICINE INC (PRME:NASDAQ)
$3.78 -0.45 (-10.6383%)
Analysed PRIME MEDICINE INC (PRME:NASDAQ) News Sources
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
18-06-2026
yahoo.com
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
22-06-2026
yahoo.com
Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?
03-07-2026
yahoo.com
Here’s Why H.C. Wainwright Upgraded Prime Medicine (PRME) To “Buy”
05-07-2026
yahoo.com
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
08-07-2026
biopharmadive.com
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
08-07-2026
yahoo.com
PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug
08-07-2026
stocktwits.com
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle
08-07-2026
yahoo.com
Beam Therapeutics (BEAM) Faces New AATD Rival PM647 Ruling What Does It Signal Strategically?
09-07-2026
yahoo.com
Cathie Wood Dumps AMD, Doubles Down on Meta Stock
10-07-2026
yahoo.com
What is the current price of PRIME MEDICINE INC (PRME:NASDAQ)?
The current price of PRIME MEDICINE INC (PRME:NASDAQ) is $3.78.
PRIME MEDICINE INC (PRME:NASDAQ) absolute price change since previous trading day?
The absolute price change of PRIME MEDICINE INC (PRME:NASDAQ) since the previous trading day is $-0.45.
PRIME MEDICINE INC (PRME:NASDAQ) percentage price change since previous trading day?
The percentage price change of PRIME MEDICINE INC (PRME:NASDAQ) since the previous trading day is -10.6383%.
What is the most recent average sentiment score for PRIME MEDICINE INC (PRME:NASDAQ)?
The most recent average sentiment score for PRIME MEDICINE INC (PRME:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for PRIME MEDICINE INC (PRME:NASDAQ)?
The most recent sentiment for PRIME MEDICINE INC (PRME:NASDAQ) is .
SEC-8K** Filing Available For PRIME MEDICINE INC (PRME:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.